Deregulation of RPL15 expression enhances the translation of RPs and E2F pathway proteins to promote breast cancer metastasis, while mutations in RPs, including RPL10 and RPS15, also provide a potential oncogenic mechanism. This evidence concerns the gene RPL15 and breast cancer.